Cracking the moody brain: lifting the mood with ketamine.
Mood and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, New York, USA. james.murrough@mssm.edu
James W
JW
Murrough
Dennis S
DS
Charney
D000928:Antidepressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy*; D018698:Glutamic Acid / Q000378:metabolism*; D006801:Humans; D007649:Ketamine / Q000494:pharmacology* / Q000627:therapeutic use; D008959:Models, Neurological; D011485:Protein Binding / Q000187:drug effects; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors* / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism
D000928:Antidepressive Agents; D016194:Receptors, N-Methyl-D-Aspartate; D018698:Glutamic Acid; D007649:Ketamine; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases